02.10.2018
- Eli Lilly has entered into an agreement with Chugai Pharmaceutical for the Japanese drugmaker’s oral non-peptidic GLP-1 receptor agonist OWL833, which is currently being developed...
12.04.2013
- Swiss drugmaker Roche has no plans to change its holding in Japan's Chugai Pharmaceutical and the recent weakening of the yen would not be a reason to trigger such a move. Asked if...
